NBC Securities’s Teva Pharmaceuticals TEVA Stock Holding History

NBC Securities’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-500	Closed	-$5K	–	2223
2023 Q3	$5K	Buy	+500	New	+$4.66K	﹤0.01%	1880

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

NBC Securities's TEVA Position: Q4 2023 in Review

NBC Securities sold out of Teva Pharmaceuticals (TEVA) in Q4 2023, closing a stake of 500 shares — an estimated $5K sold.

NBC Securities first reported a position in TEVA in Q3 2023 and held it in 1 quarter. The position peaked at $5K in Q3 2023. 447 funds tracked by Wall St. Rank hold TEVA as of Q4 2023.

NBC Securities reported no remaining Teva Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
NBC Securities sold 500 Teva Pharmaceuticals shares in Q4 2023, an estimated $5K.
NBC Securities first reported a position in Teva Pharmaceuticals in Q3 2023 and held it in 1 quarter.
NBC Securities's Teva Pharmaceuticals position peaked at $5K in Q3 2023.
447 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2023.

Based on NBC Securities's 13F filing for Q4 2023, filed 7 Feb 2024.